Nature Reviews Immunology Submission Guide

Source: Clarivate JCR 2024, Nature Reviews Immunology editorial disclosures (accessed April 2026).

Source: Nature Reviews Immunology author guidelines, Springer Nature.

Use this page when you are still deciding:

• whether the topic has timing and novelty headroom relative to recent reviews
• whether the scope is broad enough for a broad immunology readership
• whether the author team's standing supports a Nature Reviews piece
• what the inquiry letter must accomplish

Before submitting a pre-submission inquiry, the proposal should make four things clear in one page:

• the specific topic or argument the synthesis will advance
• why the synthesis is needed now (recent immunology paradigm shift, technological inflection, public-health moment)
• what differentiates the proposal from existing reviews on adjacent topics
• why this author team is positioned to write the definitive synthesis

At minimum, the inquiry includes:

• a working title that states the synthesis
• a 200-300 word scope outline
• a "why now" paragraph naming recent immunology developments
• a paragraph distinguishing from existing reviews
• a candidate author list with primary-research credentials
• a proposed length and figure structure

Common failures here are timing and authority failures:

• The proposed topic was reviewed within 24 months. Editors check existing literature before responding.

• The "why now" case is generic. "Recent advances in [immunology topic]" is not a why-now case. Editors look for a specific inflection.

• The angle is not differentiated. A proposal structurally indistinguishable from a recent review even if the topic is technically new.

• The author team lacks primary-research depth. If no proposed author has published primary research in the proposed topic within 5 years, the proposal is typically returned.

NRI is a venue for definitive immunology syntheses, not surveys or original research findings.

The commissioning model: roughly 70-80% of published pieces start with a Nature Reviews editor approaching a researcher. Pre-submission inquiries compete against pieces editors are already developing.

The 24-month timing window: NRI rarely commissions a comprehensive review of a topic covered in NRI, Annual Review of Immunology, Immunity Reviews, or Trends in Immunology within the last 24 months.

The breadth standard: the journal serves immunologists across innate, adaptive, cellular, infection, tumor, autoimmunity, and vaccine immunology. A Review useful only to a single sub-discipline is usually redirected.

The proposal needs:

• a synthesis-level argument with cross-subfield implications
• one defensible "why now" inflection point
• author credentials signaling authority on the specific topic
• a clear point of view, not a neutral summary

The strongest NRI inquiries sound like one editor briefing another on a piece worth commissioning.

They usually:

• state the central argument in one sentence
• explain why the synthesis is needed in this 18-month window
• distinguish from 2-3 existing reviews
• establish author credentials in 2-3 sentences
• propose a working title and section outline

• Is Nature Reviews Immunology a good journal?
• Nature Reviews Microbiology submission guide

Before drafting the inquiry, run your proposal through a Nature Reviews Immunology pre-submission readiness check.

In our pre-submission review work with proposals targeting NRI, three patterns generate the most consistent inquiry rejections.

In our experience, roughly 40% of NRI inquiry rejections trace to timing collisions with existing reviews. In our experience, roughly 25% involve weak differentiation despite acceptable timing. In our experience, roughly 20% arise from author teams without primary-research credentials in the proposed topic.

• The proposed topic was comprehensively reviewed within 24 months. NRI editors check the recent literature. We observe that proposals on topics covered in NRI, Annual Review of Immunology, Trends in Immunology, or Immunity Reviews within 18-24 months are routinely declined unless the new proposal articulates a clearly distinct angle. SciRev community data on Nature Reviews journals consistently shows topic timing as a top filter.

• The why-now case is generic. Editors at NRI look for a specific inflection: a converging dataset, a clinical trial result, a vaccine development moment, a technological breakthrough. We see many proposals that frame timing as "recent advances" without naming the specific event that justifies a synthesis now. Successful proposals name the inflection (e.g., "post-COVID rethinking of mucosal immunity," "the 2024 cancer vaccine results").

• The author team lacks recent primary-research depth in the proposed topic. Editors weigh authority heavily. We find that proposals where no listed author has published primary research on the proposed topic within the last 5 years are routinely rejected at inquiry stage. A Nature Reviews Immunology inquiry-readiness check can identify whether your timing, angle, and author authority case is sufficient before submission.

Clarivate JCR 2024 bibliometric data places NRI in the top decile of immunology journals. SciRev author-reported data confirms typical 1-3 week response windows for inquiries.